Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
07 Sep 2022
Notification regarding unquoted securities - ATX
07 Sep 2022
Change of Director's Interest Notice - Dr. Warwick Tong
07 Sep 2022
Change of Director's Interest Notice - Dr. Robert Peach
07 Sep 2022
Change of Director's Interest Notice - Dr. Christopher Burns
07 Sep 2022
Change of Director's Interest Notice - Mrs. Jane Bell
06 Sep 2022
Change of Director's Interest Notice - Dr. John Lambert
02 Sep 2022
Notification of cessation of securities - ATX
31 Aug 2022
Amplia Receives $1.8m R&D Tax Incentive
25 Aug 2022
Results of Annual General Meeting
25 Aug 2022
CEO & Managing Director Presentation to AGM
Previous
1
2
3
4
5
6
Next
